Penny Jeffery

Positions
- Research Fellow, APCRC-Q, Queensland University of Technology
- Lecturer, Faculty of Medicine, University of Queensland
Related websites and profiles
Qualifications
PhD, Molecular Biotechnology, Queensland University of Technology, Australia, 2006
BSc App Sci (Hons), Applied Science, Queensland University of Technology, Australia, 2001
Biography
Dr Jeffery is a mid-career medical researcher with a focus on the action and regulation of metabolic hormones in the context of endocrine disorders and cancer. Dr Jeffery has extensive experience with animal models of metabolic dysfunction and cancer and collaborates with researchers and clinicians in the UK, Europe and the USA. Dr Jeffery has published in high impact journals including Nature Genetics, Journal of Clinical Endocrinology and Metabolism and Gastroenterology and has received funding from national and international funding agencies. She has a strong commitment to education and training and has supervised many successful higher degree students and currently teaches medical and biomedical science students at all levels.
Awards and grants
Awards
Year |
Title |
2006 |
QUT Dean’s Award for Academic Excellence (PhD) |
2006 |
Finalist, Queensland Premier’s Awards for Medical Research, Australian Society for Medical Research |
2004 |
Winner of the QLD government Smart Women, Smart State Award |
2004 |
Finalist, Young cancer researcher of the year, Cure Cancer Foundation, Australia |
2003 |
QUT travel award to give invited seminars and lab visits in the National Institute of Medical Research (London) and Faculty of Medicine, University of Cordoba, Cordoba Spain |
2003 |
Finalist, Novartis junior Investigator Awards, Endocrine Society of Australia |
2002 |
Postgraduate Travel Award, Endocrine Society of Australia, Oral Presentation, Adelaide |
2000 |
Australian Postgraduate Award plus Dean’s top up Scholarship |
Grants
Year |
Funding Agency |
Title |
Investigators |
2017-2018 |
Australian Pediatric Endocrinology Group (APEG) |
Predicting good and poor responders to recombinant human growth hormone therapy |
R Pelekanos, Y Musthaffa, P Jeffery, M Harris, I Hughes |
2017-2018 |
School of Biomedical Sciences, QUT |
HDAC11 as a novel target for obesity |
P Jeffery, G Crisp |
2016-2017 |
Foundation for Prader-Willi Research (USA) |
Characterisation of autoantibodies in Prader-Willi Syndrome
|
L Chopin, P Jeffery, M Harris, I Seim, G Crisp, I Hughes |
2016-2017 |
Australian Pediatric Endocrinology Group (APEG) and Novonordisk |
Energy Homeostasis in Prader-Willi Syndrome |
Jeffery P, Harris J, Nyunt |
2017-2018 |
Institute of Health and Biomedical Innovation, Queensland University of Technology |
Insights into growth outcomes in paediatric Turner Syndrome from high-throughput epigenome and transcriptome analyses - a pilot study |
P Jeffery |
2010-2013 |
Queensland Government |
Smart Futures Fellowship |
P Jeffery |
2008-2009 |
Perpetual Foundation |
Ghrelin in Paediatric IBD |
P Jeffery |
2007-2009 |
NHMRC Project Grant |
Novel therapeutics in IBD |
P Jeffery, R Eri |
2005-2009 |
NHMRC |
Peter Doherty Biomedical Training Fellowship |
P Jeffery |
Research interests
Animal models of metabolic dysfunction, cancer, prostate cancer, Prader-Willi Syndrome, autoantibodies, paediatric Turner syndrome, high-throughput epigenome and transcriptome analyses
Current research projects
Predicting good and poor responders to recombinant human growth hormone therapy.
HDAC11 as a novel target for obesity.
Top publications
- Seim I, Jeffery PL, Thomas PB, Nelson CC, Chopin LC (2017) Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines. G3 7:1731-1741.
- Seim I, Crisp GJ, Shah ET, Jeffery PL, Chopin LK (2017) Abundant ghrelin gene expression by monocytes: Putative implications for fat accumulation and obesity. Obesity Medicine 5:1-3.
- Maugham ML, Thomas PB, Crisp GJ, Philp LK, Shah ET, Herington AC, Chen C, Gregory LS, Nelson CC, Seim I, Jeffery PL*, Chopin LK* (2017) Insights from engraftable immunodeficient mouse models of hyperinsulinaemia. Sci Rep 7:491. *Co-corresponding author
- Sheng Y, Ng CP, Lourie R, Shah ET, He Y, Wong KY, Seim I, Oancea I, Morais C, Jeffery PL, Hooper J, Gobe GC, McGuckin MA (2017) MUC13 overexpression in renal cell carcinoma plays a central role in tumor progression and drug resistance. Int J Cancer 140:2351-2363.
- Seim, Jeffery, Herington and Chopin (2014) Turtle ghrelin. Nature Genetics 46:525
- Fung, Jeffery, Lee, Seim, Roche, Obermair, Chopin, Chen (2013) Silencing of Ghrelin Receptor Expression Inhibits Endometrial Cancer Cell Growth in vitro and in vivo Am. J. Physiol. Endocrinol. Metab. 305(2):E305-13.
- Yeh AH*, Jeffery PL*, Duncan RP, Herington AC, Chopin LK (2005) Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer compared to normal prostate tissue and ghrelin-mediated prostate cancer cell line proliferation involves the MAPK pathway. Clin Cancer Res 11:8295-8303. *equal first authorship
- Jeffery PL, Murray RE, Yeh AH, McNamara JF, Duncan RP, Francis G, Herington AC, Chopin LK (2005) Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer 12:839-850.
- Jeffery PL, Herington AC, Chopin LK (2003) The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytokine Growth Factor Rev 14: 113-122.
- Jeffery PL, Herington AC, Chopin LK (2002) Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cells lines. J Endocrinol 172: 7-11.
Team
Higher degree student supervision: Primary: Gabrielle Crisp; Associate: Patrick Thomas, Michelle Maugham, Esha Shah, Hongzhuo Li (UQ)
Collaborators
Dr Mark Harris, Dr Yassmin Musthaffa, Dr Emily Papadimos (Lady Cilento Children’s Hospital); Professor Chen Chen, Dr Rebecca Pelekanos (UQ), Claudio Pietra (Helsinn Pharmaceuticals)
Professional memberships and associations
Year |
Title, Organisation |
2006 - present |
Australian Society for Medical Research |
2016 - present |
European Society for Paediatric Endocrinology |
2001 - present |
Endocrine Society of Australia, Australian Society for Medical Research |